Plasmid-mediated mcr-1 in carbapenem-susceptible Escherichia coli ST156 causing a blood infection: an unnoticeable spread of colistin resistance in Brazil?
Clinics; 72 (10), 2017
Publication year: 2017
OBJECTIVE:
We describe an IncX4 pHC891/16mcr plasmid carrying mcr-1 in a colistin-resistant and carbapenem-susceptible E. coli isolate (HC891/16), ST156, which caused a blood infection in a Brazilian patient with gallbladder adenocarcinoma.METHODS:
Strain HC891/16 was subjected to whole genome sequencing using the MiSeq Platform (Illumina, Inc., USA). Assembly was performed using Mira and ABACAS.RESULTS:
The isolates showed resistance only to ciprofloxacin, ampicillin and cefoxitin, and whole-genome sequencing revealed the presence of aac(6')Ib-cr and blaTEM1.CONCLUSION:
Our findings warn of the possible silent dissemination of colistin resistance by carbapenem-susceptible mcr-1 producers, as colistin susceptibility is commonly tested only among carbapenem-resistant isolates.
Antibacterianos/farmacología, Bacteriemia/tratamiento farmacológico, Brasil, Carbapenémicos/farmacología, Colistina/farmacología, Farmacorresistencia Bacteriana Múltiple, Escherichia coli/efectos de los fármacos, Escherichia coli/genética, Escherichia coli/aislamiento & purificación, Infecciones por Escherichia coli/tratamiento farmacológico, Proteínas de Escherichia coli/efectos de los fármacos, Proteínas de Escherichia coli/genética, Proteínas de Escherichia coli/aislamiento & purificación, Pruebas de Sensibilidad Microbiana, Plásmidos/efectos de los fármacos